| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
Kaiser Permanente
| Professional | $1,263.49 | $2,511.00 | $2,825.62 | |
United
| Professional | $924.50 | $1,118.00 | $1,758.96 |
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the COVID-19 public health emergency
| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
Kaiser Permanente
| Professional | $1,263.49 | $2,511.00 | $2,825.62 | |
United
| Professional | $924.50 | $1,118.00 | $1,758.96 |